RESUMEN
This study aimed to investigate if the duration of breastfeeding and the method at initiation of complementary feeding affect eating behaviour in children aged 3-6 years. This is a cross-sectional analysis from the Childhood Obesity Risk Assessment Longitudinal Study project, an ongoing longitudinal cohort study that aims to identify childhood obesity risk factors in Spanish children. A total of 1215 children aged 3-6 years were included. Breastfeeding duration and the method of initiation of complementary feeding [baby-led weaning (BLW), traditional/spoon or mixed method] were evaluated. Eating behaviour at 3-6 years was assessed with the Child Eating Behaviour Questionnaire. Generalized linear models were fitted to assess the association between the aforementioned exposures and eating behaviour. Children breastfed for ≥4 months were less likely to be fussy eaters at 3-6 years compared to those breastfed for <1 month (OR: 0.86 95% CI: 0.76-0.98; p = 0.031). Compared to those children using the traditional/spoon-feeding method, those initiating complementary feeding through BLW or through a mixed approach were more likely to have higher scores on the enjoyment of food (EF) (OR, 95% CI: 1.33, 1.13-1.57; p = 0.001 and 1.17, 1.05-1.30; p = 0.002, respectively) and lower scores on food fussiness (FF) at 3-6 years (0.76, 0.62-0.91; p = 0.004 and 0.87, 0.78-0.98; p = 0.033, respectively). Breastfeeding for ≥4 months and initiation of complementary feeding with the BLW and a mixed approach were associated with greater EF and lower FF, which should endure practice.
RESUMEN
Vitamin D deficiency has been associated with a higher risk of multiple diseases, including cardiovascular disorders. The purpose of this study was to examine the potential association between predicted levels of serum 25(OH)D and the risk of new-onset hypertension in a large Mediterranean cohort. A validated 136-item food frequency questionnaire was used as the dietary assessment tool. 25(OH)D serum levels were predicted using a previously validated equation. We performed Cox regression models to analyze the association between predicted serum 25(OH)D and the risk of hypertension, according to quartiles of forecasted vitamin D at baseline, after adjusting for multiple potential confounders. Over a median follow-up of 12.3 years, 2338 new cases of hypertension were identified. The analyses revealed a significant inverse association between predicted serum levels of 25(OH)D at baseline and the risk of hypertension. Individuals in the highest quartile showed a 30% relatively lower risk of hypertension compared to the lowest quartile (hazard ratio (HR): 0.70; 95% confidence interval (CI): 0.60-0.80, p-trend < 0.001). The outcomes remained significant after performing sensitivity analyses. The findings suggested that higher levels of forecasted vitamin D are inversely and independently associated with the risk of incident hypertension, implying that vitamin D may offer protective benefits against the disease.
Asunto(s)
Hipertensión , Deficiencia de Vitamina D , Vitamina D , Humanos , Vitamina D/sangre , Vitamina D/análogos & derivados , Hipertensión/epidemiología , Hipertensión/etiología , Hipertensión/sangre , Masculino , Femenino , Estudios Prospectivos , Persona de Mediana Edad , Deficiencia de Vitamina D/epidemiología , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/complicaciones , Factores de Riesgo , Adulto , Modelos de Riesgos Proporcionales , IncidenciaRESUMEN
OBJECTIVE: To examine whether eating behavior and perceived stress predict the maintenance of self-reported dietary change and adherence to dietary instructions during an intervention. DESIGN: A secondary analysis of the behavior maintenance stage (6-36 months) of the 3-year PREVIEW intervention (PREVention of diabetes through lifestyle Intervention and population studies in Europe and around the World). PARTICIPANTS: Adults (n = 1,311) with overweight and prediabetes at preintervention baseline. VARIABLES MEASURED: Eating behavior (Three-Factor Eating Questionnaire), stress (Perceived Stress Scale), and dietary intake (4-day food records on 4 occasions) were reported. ANALYSIS: Associations between predictors and dietary outcomes were examined with linear mixed-effects models for repeated measurements. RESULTS: Eating behaviors and stress at 6 months did not predict the subsequent change in dietary outcomes, but higher cognitive restraint predicted lower energy intake, and both higher disinhibition and hunger predicted higher energy intake during the following behavior maintenance stage. In addition, higher disinhibition predicted higher saturated fat intake and lower fiber intake, and higher hunger predicted lower fiber intake. Stress was not associated with energy intake or dietary quality. Eating behaviors and stress were not consistently associated with adherence to dietary instructions. CONCLUSIONS AND IMPLICATIONS: Higher cognitive restraint predicted lower energy intake (food quantity), but disinhibition and hunger were also associated with dietary quality.
Asunto(s)
Conducta Alimentaria , Estrés Psicológico , Humanos , Femenino , Masculino , Conducta Alimentaria/psicología , Conducta Alimentaria/fisiología , Persona de Mediana Edad , Estrés Psicológico/psicología , Adulto , Sobrepeso/psicología , Estado Prediabético/psicología , Dieta/estadística & datos numéricos , Dieta/psicología , AncianoRESUMEN
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies directed against endogenous antigens causing various clinical manifestations, chronic inflammation and tissue damage. Although the pathophysiology of SLE remains unknown, it is recognized that genetic, epigenetic, environmental and neuroendocrine factors are involved in the development of the disease and its complications. A notable proportion of patients with SLE also present obesity, and this dysmetabolic profile can cause renal, musculoskeletal and/or respiratory deterioration, fatigue, various pathophysiological alterations and functional deterioration. In this context, precision nutrition emerges as a promising tool in the inflammatory control of SLE, especially in patients with associated obesity. Various studies demonstrate the beneficial influence of balanced dietary patterns in macronutrients with foods rich in fiber, vitamins, minerals, antioxidants and polyphenols on the inflammatory control of SLE and the most diverse pathologies, highlighting the Mediterranean diet and plant-based diets. Finally, the intestinal microbiota may play a relevant role in this clinical scenario, since dysbiosis is associated with inflammatory processes and immune deregulation. It is believed that precision nutrition can modulate inflammatory profiles and immune dysfunctions to ensure better quality of life and metabolic well-being of SLE patients with the support of precision omics technologies.
El lupus eritematoso sistémico (LES) es una enfermedad autoinmune caracterizada por la producción de autoanticuerpos dirigidos contra antígenos endógenos causando diversas manifestaciones clínicas, inflamación crónica y daño tisular. Aunque la fisiopatología del LES sigue siendo desconocida, se reconoce que factores genéticos, epigenéticos, ambientales y neuroendocrinos están implicados en el desarrollo de la enfermedad y sus complicaciones. Una proporción notable de pacientes con LES presenta también obesidad, y este perfil dismetabólico puede producir deterioro renal, musculoesquelético y/o respiratorio, fatiga, diversas alteraciones fisiopatológicas y deterioro funcional. En este contexto, la nutrición de precisión emerge como una herramienta prometedora en el control inflamatorio del LES, especialmente en pacientes con obesidad asociada. Diversos estudios demuestran la influencia beneficiosa de patrones dietéticos equilibrados en macronutrientes con alimentos ricos en fibra, vitaminas, minerales, antioxidantes y polifenoles en el control inflamatorio del LES y de las más diversas patologías, destacando la dieta Mediterránea y las dietas basadas en plantas/vegetales. Por último, la microbiota intestinal puede tener un papel relevante en este escenario clínico, ya que la disbiosis se asocia con procesos inflamatorios y desregulación inmune. Se cree que con la nutrición de precisión se pueden modular los perfiles inflamatorios y las disfunciones inmunitarias para garantizar una mejor calidad de vida y el bienestar metabólico de los pacientes con LES con el apoyo de las tecnologías de precisión ómicas.
RESUMEN
Background: some studies have evaluated the association of the rs1805134 genetic variant of the LEPR gene with obesity. Aims: the objective was to explore the association of the rs1805134 genetic variant of the LEPR gene with obesity measures and metabolic syndrome in obese Caucasian adults. Methods: we conducted a cross-sectional study in 212 obese subjects with body mass index (BMI) greater than 30 kg/m2. Measurements of adiposity parameters, blood pressure, fasting blood glucose, insulin concentration, insulin resistance (HOMA-IR), lipid profile, C-reactive protein, and prevalence of metabolic syndrome were determined. Results: the distribution of rs1805134 was 128 TT (60.4 %), 77 TC (36.3 %), and 7 CC (3.3 %). C-allele carriers showed higher levels of BMI, body weight, body fat mass, waist circumference, insulin, HOMA-IR, triglycerides, total energy intake, and carbohydrate intake than non-C-allele carriers. A logistic regression analysis reported a high percentage of elevated waist circumference (OR = 2.22, 95 % CI = 1.201-4.97; p = 0.02), hyperglycemia (OR = 1.54, 95 % CI = 1.01-5.44; p = 0.01), and metabolic syndrome percentage (OR = 1.41, 95 % CI = 1.04-5.39; p = 0.03) in C-allele carriers. Conclusions: subjects with the C-allele of the rs1805134 variant of the LEPR gene showed a worse metabolic pattern with a higher percentage of metabolic syndrome, central obesity and hyperglycaemia, probably related to higher energy intake. (AU)
Antecedentes: algunos estudios han evaluado la asociación de la variante genética rs1805134 del gen LEPR con la obesidad. Objetivos: el objetivo fue explorar la asociación de la variante genética rs1805134 del gen LEPR con los parámetros de obesidad y síndrome metabólico en adultos caucásicos obesos. Métodos: realizamos un estudio transversal en 212 sujetos obesos con índice de masa corporal (IMC) superior a 30 kg/m2 . Se determinaron los parámetros de adiposidad, presión arterial, glucemia en ayunas, concentración de insulina, resistencia a la insulina (HOMA-IR), perfil lipídico, proteína C-reactiva y prevalencia de síndrome metabólico. Resultados: la distribución del rs1805134 fue de 128 TT (60,4 %), 77 TC (36,3 %) y 7 CC (3,3 %). Los portadores del alelo C mostraron niveles más altos de IMC, peso corporal, masa grasa corporal, circunferencia de la cintura, insulina, HOMA-IR, triglicéridos, ingesta total de energía y consumo de carbohidratos que los portadores sin alelo C. El análisis de regresión logística mostró un alto porcentaje de pacientes con elevada circunferencia de la cintura (OR = 2,22, IC 95 % = 1,201-4,97; p = 0,02), hiperglucemia (OR = 1,54, IC 95 % = 1,01-5,44; p = 0,01) y síndrome metabólico (OR = 1,41, IC 95 % = 1,04-5,39; p = 0,03) en los portadores del alelo C. Conclusiones: los sujetos con alelo C de la variante rs1805134 del gen LEPR mostraron un peor patrón metabólico con mayor porcentaje de síndrome metabólico, obesidad central e hiperglucemia, probablemente relacionado con una mayor ingesta energética. (AU)
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Polimorfismo Genético , Ingestión de Energía , Estudios Transversales , Síndrome Metabólico , Ingestión de Alimentos , ObesidadRESUMEN
Introduction: rs822393 is related to dietary intervention responses. The aim of our study was to analyze the metabolic effects of 2 hypocaloric diets with a different fat profile during 3 months according to the genetic variant rs822393. Methods: a population of 361 obese patients were randomly allocated to one of two diets; Diet P (enriched in polyunsaturated fatty acids) vs. Diet M (enriched in monounsaturated fatty acids). Adiposity and biochemical parameters were determined. rs822393 was assessed by real-time PCR, with a dominant model analysis (CC vs CT+TT). Results: genotype distribution was: 221 CC (61.2 %), 115 CT (31.9 %) and 25 TT (6.9 %). Basal and post-intervention HDL cholesterol, adiponectin levels and adiponectin/leptin ratio were lower in T-allele than non-T-allele carriers. After both diets, BMI, weight, fat mass, waist circumference, systolic blood pressure, insulin levels, HOMA-IR, leptin, total cholesterol and LDL-cholesterol improved significantly in both genotype groups. After Diet P, HDL-cholesterol (delta: 5.6 ± 1.1 mg/dl vs. 2.7 ± 0.9 mg/dl; p = 0.01), serum adiponectin (20.1 ± 2.9 ng/dl vs. 6.8 ± 3.0 ng/dl; p = 0.02) and adiponectin/leptin ratio (0.57 ± 0.1 units vs. 0.20 ± 0.08 units; p = 0.03) improved in non-T allele carriers. The same improvements were observed after Diet M: HDL-cholesterol (delta: 5.5 ± 0.8 mg/dl vs. 3.1 ± 0.9 mg/dl; p = 0.03), serum adiponectin (19.5 ± 2.9 ng/dl vs. 4.5 ± 2.8 ng/dl; p = 0.01), and adiponectin/leptin ratio (0.54 ± 0.1 units vs. 0.15 ± 0.08 units; p = 0.03). These parameters remained unchanged in T-allele carriers. (AU)
Introducción: el polimorfismo rs822393 está relacionado con las respuestas a las intervenciones dietéticas. El objetivo de nuestro estudio fue analizar los efectos metabólicos de 2 dietas hipocalóricas con diferente perfil graso durante 3 meses según la variante genética rs822393. Métodos: una muestra de 361 pacientes obesos se asignó aleatoriamente a una de dos dietas: dieta P (enriquecida en ácidos grasos poliinsaturados) y dieta M (enriquecida en ácidos grasos monoinsaturados). Se determinaron parámetros de adiposidad y bioquímicos; rs822393 se evaluó mediante PCR en tiempo real, con un análisis de modelo dominante (CC frente a CT+TT). Resultados: la distribución del genotipo fue: 221 CC (61,2 %), 115 CT (31,9 %) y 25 TT (6,9 %). El colesterol HDL basal y posterior a la intervención, los niveles de adiponectina y la relación adiponectina/leptina fueron más bajos en los portadores del alelo T que en los no portadores del alelo T. Tras la intervención con ambas dietas, el IMC, el peso, la masa grasa, la circunferencia de la cintura, la presión arterial sistólica, los niveles de insulina, el HOMA-IR, la leptina, el colesterol total y el colesterol LDL mejoraron significativamente en ambos grupos de genotipo. Después de la dieta P: HDL-colesterol (delta: 5,6 ± 1,1 mg/dl vs. 2,7 ± 0,9 mg/dl; p = 0,01), adiponectina sérica (20,1 ± 2,9 ng/dl vs. 6,8 ± 3,0 ng/dl; p = 0,02) y la relación adiponectina/leptina (0,57 ± 0,1 unidades frente a 0,20 ± 0,08 unidades; p = 0,03) mejoraron en los no portadores del alelo T. Se observaron los mismos resultados después de la dieta M: HDL-colesterol (delta: 5,5 ± 0,8 mg/dl frente a 3,1 ± 0,9 mg/dl; p = 0,03), adiponectina sérica (19,5 ± 2,9 ng/dl frente a 4,5 ± 2,8 ng /dl; p = 0,01) y relación adiponectina/leptina (0,54 ± 0,1 unidades vs. 0,15 ± 0,08 unidades; p = 0,03). Estos parámetros permanecieron sin cambios en los portadores del alelo T. (AU)
Asunto(s)
Humanos , Masculino , Femenino , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Polimorfismo Genético , Obesidad/dietoterapia , Dieta , Grasas de la Dieta , EspañaRESUMEN
El envejecimiento de la población supone un importante reto, económico y cualitativo, para el sistema de salud orientándolo hacia una atención de tipo preventivo, en la que la nutrición de precisión (NP) y la prescripción de hábitos saludables adquieren relevancia capital. El fin de la NP es procurar una nutrición adaptada a cada individuo, entendiendo que la prevención o el tratamiento de trastornos crónicos (obesidad, diabetes, enfermedad cardiovascular, etc.) deben abordarse de un modo integral, considerando información personal y clínica relevante, edad y características feno- y genotípicas. La elaboración de la presente guía surge de la necesidad de desarrollar modelos nutricionales de precisión que permitan la individualización del tratamiento nutricional, con énfasis en el adulto mayor. Las necesidades nutricionales, las recomendaciones dietéticas y los ingredientes para una NP en las personas pre-sénior y sénior quedan resumidas en realizar al menos 3 comidas diarias, reducir las calorías totales, optar por una alimentación variada y equilibrada con alimentos frescos y de alta densidad nutricional, incorporar verduras, legumbres y pescado, consumir productos lácteos y fibra, preferir carnes blancas en lugar de rojas, evitar frituras, embutidos y alimentos procesados, moderar el consumo de sal, café y alcohol, e hidratarse adecuadamente
The aging of the population underlines an important challenge for the health system not only from sanitary and economic reasons but also by quality perspectives concerning preventive care, where precision nutrition (PN) and the prescription or advice on healthy habits becomes relevant. PN focuses on provide nutrition adapted to each individual, understanding that the prevention or treatment of chronic disorders (obesity, diabetes, cardiovascular disease, etc.) must be addressed in a comprehensive way, considering not only relevant personal and clinical information, but also healthy aging and phenotypical and genotypical features. This guide was prepared due to the need to develop precision nutritional models that allow individualized nutritional treatment for each subject and physiopathological particularities with emphasis on the elderly. Therefore, the requirements of the Spanish pre-senior and senior populations, dietary recommendations and precision foods are reviewed in this document: have at least three daily meals, reduce total calories, choose a varied and balanced diet with fresh foods and high nutritional density, add vegetables, legumes and fish, consume dairy products and fiber, prefer white meat instead of red, avoid fried foods, sausages and processed foods, moderate the consumption of salt, coffee and alcohol, and get hydrated
Asunto(s)
Humanos , Anciano , Medicina de Precisión/métodos , Terapia Nutricional/métodos , Enfermedad Crónica/terapia , Trastornos Nutricionales/dietoterapia , Modelación Específica para el Paciente , Afecciones Crónicas Múltiples/terapia , Estado Nutricional , Nutricion del AncianoRESUMEN
No disponible
Asunto(s)
Humanos , Cacao , Polifenoles , Trastornos del Conocimiento/dietoterapia , Demencia/dietoterapia , Disonancia Cognitiva , 24457 , Salud Pública/métodos , Evaluación NutricionalRESUMEN
No disponible
Asunto(s)
Humanos , Enfermedades Cardiovasculares/prevención & control , Síndrome Metabólico/fisiopatología , Hígado Graso , 57923/tendencias , Síndrome Metabólico/etiología , Estilo de Vida , Hígado Graso/fisiopatología , Medición de RiesgoRESUMEN
Mediante una aproximación epigenómica, se analizaron las posibles asociaciones entre los niveles basales en la metilación del ADN y una mejor respuesta a la pérdida de peso después de un programa de intervención nutricional en la población obesa del estudio RESMENA. Esta investigación ha identificado 3 regiones de ADN (genes RGS6, A2BP1 y RASGRF1) que se encuentran diferencialmente metiladas entre sujetos con alta y baja respuesta a la pérdida de peso. Además, estos genes están implicados en la misma ruta metabólica y habían sido previamente significativamente asociados con la obesidad
Through anepigenomics approach, the possible association between baseline levels in DNA methylation and a better weight loss response after a multidisciplinary intervention program were analyzedin obese population from RESMENA-S study. Three DNA regions that are differentially methylated (RGS6, A2BP1 and RASGRF1 genes) showed differential methylation levels at baseline between high and low responders to the multidisciplinary weight loss intervention. Moreover, these genes were implicated in the same metabolic pathway and have been previously significantly associated with obesity
Asunto(s)
Humanos , Masculino , Femenino , Epigenómica/métodos , Epigenómica/tendencias , Pérdida de Peso , Metilación , Metilación de ADN , Fenómenos Fisiológicos de la Nutrición , Trastornos Nutricionales/tratamiento farmacológicoRESUMEN
O estado inflamatório crônico e de baixo grau bem como o estresse oxidativo associados à síndrome metabólica são fatores de risco relevantes para o desenvolvimento de doenças cardiovasculares. Neste contexto, o selênio é um mineral essencial que se encontra associado com o correto funcionamento dos principais processos metabólicos celulares. Estudos in vitro e in vivo em modelos experimentais de síndrome metabólica, bem como em humanos, tem investigado o efeito do selênio sobre a expressão e secreção de biomarcadores de inflamação e de estresse oxidativo. Para obtenção dos artigos sobre efeitos antioxidantes do selênio foram feitas pesquisas nos websites científicos. Na literatura encontramos numerosos artigos sobre os diferentes parâmetros modulados pelas concentrações plasmáticas de selênio, incluindo a proteína-C reativa, a interleucina-6, o fator de necrose tumoral-α, a interleucina-1β e a proteína transportadora de retinol-4. Esta revisão teve por objetivo discutir o papel do selênio nos processos inflamatórios e de estresse oxidativo, associados à síndrome metabólica.
The mild chronic inflammation and oxidative stress associated with metabolic syndrome are relevant risk factors for the development of cardiovascular diseases. In this context, selenium is an essential mineral associated with the correct functioning of the main metabolic processes of the cell. In vitro and in vivo studies in experimental metabolic syndrome models as well as in humans have investigated the effect of selenium on the expression and secretion of inflammation and oxidative stress biomarkers. Articles on the antioxidant effects of selenium were sought in scientific websites. There are a great number of studies in the literature on the different parameters modulated by blood selenium levels, such as C-reactive protein, interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta and retinol binding protein 4. The objective of this review is to discuss the role of selenium in inflammatory and oxidative stress processes associated with the metabolic syndrome.
Asunto(s)
Citocinas , Estrés Oxidativo , Inflamación/patología , Selenio/farmacología , Síndrome Metabólico/tratamiento farmacológicoRESUMEN
El término ácido linoleico conjugado (CLA) hace referencia a un grupo de isómeros del ácido linoleico, caracterizados por tener enlaces dobles conjugados en varias posiciones y conformaciones. El CLA se encuentra de forma natural en algunos alimentos, aunque desde que se le atribuyen efectos beneficiosos sobre varios aspectos relacionados con la salud, numerosos grupos investigadores han estudiado los efectos de la suplementación con este ácido graso. En este sentido, el efecto del CLA sobre el perfil lipídico de los animales ha sido extensamente estudiado y existen evidencias confirmadas de beneficios sobre diversos marcadores metabólicos. Sin embargo, los resultados de los ensayos de intervención en humanos son ambiguos. El objetivo de esta revisión fue reunir los datos disponibles y más actuales acerca de los efectos del CLA en el perfil lipídico de humanos. Diversos estudios no hallaron efectos significativos en ninguna de las variables estudiadas; sin embargo, otros trabajos encontraron tanto efectos beneficiosos como desfavorables en el colesterol total, c-LDL, c-HDL, índice aterogénico, triglicéridos y lipoproteína(a). Esta discrepancia podría probablemente deberse a las diferencias en la dosis, composición de isómeros y placebo utilizado, así como a la duración del estudio y al estado nutricional de los sujetos incluidos, entre otros. No obstante, el análisis de los estudios de 12 semanas de duración, realizados con una mezcla en cantidades iguales de los dos isómeros principales del CLA (cis-9, trans-11 y trans-10, cis-12) y con dosis diarias de entre 3 y 4 g aproximadamente, parecen ofrecer los resultados más beneficiosos.
The term conjugated linoleic acid (CLA) concerns a group of isomers of linoleic acid, which are characterized by having conjugated double bonds in several positions and conformations. CLA is found naturally in some foods, but since CLA was first held to cause beneficial effects on various health-related issues, many investigations have been conducted to elucidate the effects of dietary supplementation with CLA. The effects of CLA on lipid profiles on animals have been extensively studied, and there is sound evidence of its benefits in blood metabolic markers. However, clinical trials in humans have provided ambiguous results. The aim of this review was to gather up-to-date available data about the effects of CLA on human lipid profile. Although most studies did not show any significant effect in none of the studied variables, some trials reported both beneficial and detrimental effects on total cholesterol, LDL-c, HDL-c, atherogenic index, triglycerides and lipoprotein(a). This discrepancy could be due to differences in dosage, isomer composition, duration of the study, placebo and participating subjects, among others. However, studies with a duration of two weeks, carried out using a mix of equal amounts of the two main CLA isomers (9-cis, 11-trans and 10-trans, 12-cis) and with doses of 3 to 4 grams per day, seem to offer the most beneficial results.
Asunto(s)
Humanos , Ácido alfa-Linolénico , Colesterol/metabolismo , Metabolismo de los Lípidos , Lipoproteína(a) , Triglicéridos/metabolismoRESUMEN
A genômica nutricional avalia o efeito da variação genética na interação entre dieta e doenças crônicas. O objetivo deste manuscrito foi revisar os principais polimorfismos associados à obesidade, ao diabetes melito e também aos fatores da dieta. As principais interações entre polimorfismos genéticos e dieta foram: para obesidade: interleucina-6 (IL-6) com consumo energético; receptor ativado por proliferador de peroxissoma gama 2 (PPAR-gama2) e fat mass and obesity associated (FTO) com consumo de gorduras; receptor β-adrenérgico 2 (ADRB2) e receptor da melanocortina-4 (MCR4) com consumo de carboidratos; para perda de peso: proteínas desacopladoras (UCPs) com restrição calórica; para leptinemia: receptor da leptina (LEPR) com restrição calórica; para diabetes melito: PPAR-gama2 com consumo de gordura; para hipertrigliceridemia: proteína transportadora de ácidos graxos 2 (FABP2) com consumo de gordura. Os dados apresentados sugerem que a genômica nutricional é importante ao desenvolvimento da obesidade e do diabetes melito.
Nutritional genomics evaluates the effects of genetic variation in the interaction between diet and chronic diseases. The aim of this manuscript was to review the most important genetic polymorphisms associated with obesity, diabetes mellitus, and dietary factors. The main interactions among genetic polymorphisms and diet were: for obesity: interleukin-6 (IL-6) with daily intake; peroxisome proliferator-activated receptor gamma 2 (PPAR-gama2) and fat mass and obesity associated (FTO) with fat intake; β-adrenergic receptor 2 (ADRB2) and melanocortin receptor 4 (MCR4) with carbohydrate intake; or reduction in body weight: uncoupling proteins (UCPs) with restriction of energy; for leptinemia: leptin receptor (LEPR) with restriction of energy; for diabetes mellitus: PPAR-gama2 with fat intake; for hypertriglyceridemia: fatty acid-binding protein 2 (FABP2) with fat intake. The data demonstrated suggest that nutritional genomics is important for the development of obesity and diabetes mellitus.
Asunto(s)
Humanos , Diabetes Mellitus/genética , Nutrigenómica , Obesidad/genética , Polimorfismo Genético/genética , Enfermedad Crónica , Predisposición Genética a la Enfermedad , FenotipoRESUMEN
A adoção de um padrão alimentar saudável, caracterizado pelo consumo de frutas, hortaliças, carnes magras, lácteos desnatados, frutos secos e moderada ingestão de óleos vegetais e álcool, é um fator determinante para um menor risco de doenças crônicas como a obesidade, a síndrome metabólica e as doenças cardiovasculares. Esse efeito benéfico pode ser explicado, pelo menos em parte, por seu papel modulador sobre biomarcadores da sensibilidade insulínica, da aterogênese, bem como os de inflamação e de função endotelial. Por outra parte, a ingestão de componentes específicos da dieta como os ácidos graxos insaturados (oleico e alfa-linolênico) e os micronutrientes com propriedades antioxidantes (vitaminas A, E e C; selênio e zinco) vêm sendo discutida, em razão de sua potencial ação protetora perante a ocorrência das doenças crônicas e possíveis benefícios na regulação hormonal, metabólica e inflamatória que esses fatores dietéticos podem proporcionar dentro de um tratamento nutricional para a obesidade e a síndrome metabólica.
Healthy dietary pattern, characterized by the consumption of fruits, vegetables, white meats, skim dairy products, nuts and moderate intake of vegetable oils and alcohol, is an important factor for a lower risk of chronic disease such as obesity, metabolic syndrome and cardiovascular disease. This beneficial effect can be explained, at least partially, by its modulating role on biomarkers of insulin sensitivity and atherosclerosis as well as of inflammation and endothelial function. On the other hand, the intake of specific dietary factors, such as unsaturated fatty acids (oleic and alpha-linolenic) and micronutrients with antioxidant properties (vitamins A, E and C; selenium, zinc) has been discussed, due to its potential protector action due to chronic disease occurrence and its possible profits in hormonal, metabolic and inflammatory regulations that these dietetic factors can provide within a nutritional treatment to obesity and metabolic syndrome.
Asunto(s)
Humanos , Antioxidantes/administración & dosificación , Dieta , Conducta Alimentaria/fisiología , Hormonas/metabolismo , Inflamación/metabolismo , Biomarcadores/sangre , Proteína C-Reactiva/metabolismo , Enfermedades Cardiovasculares/dietoterapia , Enfermedades Cardiovasculares/prevención & control , Grasas de la Dieta/administración & dosificación , Endotelio Vascular/fisiología , Ácidos Grasos/administración & dosificación , Mediadores de Inflamación , Inflamación/dietoterapia , Síndrome Metabólico/dietoterapia , Necesidades Nutricionales , Obesidad/dietoterapia , Obesidad/metabolismo , Factores de RiesgoRESUMEN
No disponible
Scientific research is constantly looking for new molecules to be used as functional ingredients to combat obesity. The aim of the present study was to analyse whether resveratrol and conjugated linoleic acid (CLA) together could reduce body fat more efficiently than their separate administration. Thirty-six male Wistar rats were randomly divided into four groups: controls rats (C), rats treated with resveratrol (RSV), rats treated with CLA (CLA) and rats treated with a combination of resveratrol and CLA (RSV+CLA). All rats were fed on an obesogenic diet. In RSV and RSV+CLA groups, the rats received 30 mg resveratrol/kg body weight/day. In CLA and RSV+CLA groups, an equimolecular mixture of trans-10,cis-12 and cis-9,trans-11 was added to the diet to reach 0.5% of the active isomer trans-10,cis-12. After 6 weeks of treatment, white adipose tissue from different anatomical locations was dissected and weighed. Serum triacylglycerols, total and HDL cholesterols, glucose, insulin, fructosamine and TNF-á were measured. A glucose tolerance test was also performed. Separately, resveratrol and CLA significantly reduced body fat but did not do so when combined: 20% in the RSV group and 18% in CLA group but 7% in the RSV+CLA group. Resveratrol reduced serum triacylglycerols. No differences were found among groups in serum cholesterol. Resveratrol, as well as the combination RSV+CLA, improved glycaemic control. These results demonstrate that the combination RSV+CLA reduces the effectiveness of each compound on body fat-lowering action, but it maintains the positive effect of resveratrol on glycaemic control. Consequently, this combination has no usefulness in obesity prevention (AU)
Asunto(s)
Animales , Ratas , Ácidos Linoleicos Conjugados/farmacocinética , Obesidad/prevención & control , Antioxidantes/farmacocinética , Medicamento Fitoterápico , Modelos Animales de Enfermedad , Sustancias Protectoras/farmacocinética , Índice Glucémico , Quimioterapia CombinadaRESUMEN
el descubrimiento de la leptina, además de revolucionar los conocimientos fisiológicos sobre la regulación del peso corporal, ha despertado el interés por el tejido graso como órgano endocrino y por su activa contribución al establecimiento de los depósitos energéticos. La leptina, secretada principalmente por los adipocitos, interacciona con receptores hipotalámicos, siendo capaz de activar diversas rutas neuroendocrinas encargadas de controlar el balance entre la ingesta y el gasto energético. Como otras citoquinas, la leptina es también capaz de intervenir en la compleja regulación de diversos aspectos metabólicos. Desde el hallazgo de que la placenta, la mucosa gástrica o las células estelares del hígado son lugares de producción de leptina, un gran abanico de funciones se atribuyen a esta hormona; ya que parece favorecer el desarrollo fetal y en el estómago podría actuar como factor de saciedad o participar en las señales aferentes mediadas por el vago. La leptina interviene además en las respuestas inmune e inflamatoria, en la reproducción, en procesos relacionados con la angiogénesis, control de la presión arterial, lipólisis, etc. El presente artículo revisa el papel de la leptina en la regulación del peso corporal, así como diversos aspectos relacionados con la obesidad